Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-02-13
1990-11-13
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548312, C07D23300, A61K 31415
Patent
active
049702254
ABSTRACT:
Heterocyclic acids and esters useful as inhibitors of mammalian blood platelet aggregation characterized by Formula I are disclosed.
REFERENCES:
patent: 3965114 (1976-06-01), van der Burg
patent: 4237131 (1980-12-01), Wootton et al.
patent: 4330550 (1982-05-01), Lautenschlager
patent: 4709042 (1987-11-01), Mai et al.
patent: 4797493 (1989-01-01), Matsuno et al.
Bristol--Myers Squibb Company
Lee Mary C.
Uloth Robert H.
Whittenbaugh Robert C.
LandOfFree
Imidazolidine carboxylic acids and esters as blood platelet aggr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolidine carboxylic acids and esters as blood platelet aggr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidine carboxylic acids and esters as blood platelet aggr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-777147